Accelerate Diagnostics Inc EV/EBIT
¿Qué es el EV/EBIT de Accelerate Diagnostics Inc?
El EV/EBIT de Accelerate Diagnostics Inc es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Accelerate Diagnostics Inc
¿Qué hace Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas con ev/ebit similar a Accelerate Diagnostics Inc
- Centogene NV tiene EV/EBIT de N/A
- Delek US Inc tiene EV/EBIT de N/A
- Freeport Resources tiene EV/EBIT de N/A
- AMMO tiene EV/EBIT de N/A
- AMMO tiene EV/EBIT de N/A
- Ultragenyx Pharmaceutical tiene EV/EBIT de N/A
- Accelerate Diagnostics Inc tiene EV/EBIT de N/A
- Eros International Plc tiene EV/EBIT de N/A
- Deveron UAS tiene EV/EBIT de N/A
- HT Media tiene EV/EBIT de N/A
- Aguila American Gold tiene EV/EBIT de N/A
- Sri Adhikari Brothers Television Network tiene EV/EBIT de N/A
- Zicom Electronic Security Systems tiene EV/EBIT de N/A